You are here: Industry Insights > drug discovery

News List

Artificial Intelligence for Drug Development David Orchard-Webb
July 31, 2023
Artificial Intelligence (AI) is making a significant impact in the pharmaceutical industry, revolutionizing various aspects of drug discovery, development, and healthcare.
Avantor Inaugurates Expanded Singapore Hub PharmaSources
July 12, 2023
On July 11, 2023,Avantor, Inc. inaugurated its expanded Singapore Hub which includes newly added cGMP manufacturing and a world class quality control laboratory.
Phenotypic Screening and Target-Based Drug Discovery: Is it Time to Unite? Neeta Ratanghayra
May 27, 2020
With advancements in biomedical science, drug discovery has evolved different strategies. However, with this dramatic progress, concerns have emerged regarding the efficiency of translating these technical advances into safe and efficacious new drugs.
X-Chem and Excelra's GOSTAR Join Forces to Advance Drug Discovery for Challenging Targets prnasia
February 11, 2022
A new collaboration between data science and analytics leader, Excelra, and artificial intelligence pioneer X-Chem will accelerate preclinical drug discovery and aid scientists to find new drug candidates for currently hard-to-drug targets.
XtalPi Partners with Excelra for GOSTAR to Enhance its Intelligent Digital Drug Discovery and Development platform prnasia
January 19, 2022
Excelra, a leading global Data & Analytics organization, today announced the partnership for its Global Online Structure Activity Relationship Database (GOSTAR) with XtalPi Inc., an AI-based pharmaceutical biotechnology company...
SMi's 5th Annual 3D Cell Culture Conference WorldPharmaNews
January 19, 2022
3D Cell Culture is gaining momentum in the pharmaceutical industry on account of the advantages such models pose for in drug discovery, from improved clinical translation and predictivity, to patient safety and sustainability.
Charles River, Valo Enter AI-enabled Drug Discovery Pact contractpharma
January 19, 2022
Multiyear partnership will leverage Valo’s Opal Computational Platform to accelerate drug discovery and development.
Ono Pharma expands drug discovery collaboration with Neurimmune AG ExpressPharma
January 18, 2022
The collaboration focusses on creating antibody drugs against new therapeutic targets in the field of neurodegenerative diseases utilising Neurimmune’s proprietary Reverse Translational Medicine (RTM) technology platform...
Piramal to create screening facility to boost in-vitro biology capabilities CPhIonline
January 14, 2022
The move is expected to bring added value to customers by coupling biology services with existing chemistry capabilities.
Finding a new purpose for old drugs: Researchers have found promising drugs for COVID-19 WorldPharmaNews
November 05, 2021
Treatment options for COVID-19 remain limited. Researchers at the University of Helsinki and the University of Eastern Finland first searched for suitable drug targets and repurposable drugs for these...

Previous page 1 2 3 4 5 6 7 Next page